Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Congener Allogeneic Hepatocyte Transplantation Treatment in Patients With Liver Cirrhosis

NCT04806581 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT04806581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04806581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Congener Allogeneic Hepatocyte Transplantation Treatment in Patients With Liver Cirrhosis
Lead sponsor
RenJi Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
April 20, 2021
Completion date
March 31, 2025
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis